Open Access

Table IV

Description of the patients with MRONJ.

  Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8 Patient 9 Patient 10
Sex Female Female Male Female Male Female Female Female Female Female
Age 55 62 82 86 44 70 62 72 61 61
Site Sector 4 Sectors 1 and 2 Sector 2 Sector 1 Sectors 1 and 2 Sector 3 Sector 2 Sector 4 Sector 4 Sectors 3 and 4
MRONJ stage 1 1 1 1 1 1 0 0 0 0
Primary cancer Breast Breast Prostate Breast Nasopharyngeal Breast Breast Breast Breast Kidney
Concomitant treatment Capecitabine, letrozole, exemestane, everolimus, fulvestrant, palbociclib Capecitabine, cyclophosphamide Corticosteroids docetaxel trihydrate, leuprolide, enzalutamide Corticosteroids fulvestrant, palbociclib Corticosteroids methotrexate carboplatin doxorubicin Letrozole, palbociclib, fulvestrant Corticosteroids exemestane/ everolimus, fulvestrant, palbociclib, capecitabine/ cyclophosphamide Letrozole, fulvestrant, palbociclib capecitabine Tamoxifen, letrozole Sunitinib, cabozantinib
Dental check-up* Infection Infection Infection Infection / Infection Infection Infection Infection Infection
Periodontal disease** + + + +++ + +++ +++ + +
Removable prosthesis / Mx compressive Overnight wearing Mx compressive Bimaxillary Overnight wearing / / Mx Mx Md instability Mx /
Extracted teeth 45 + Non-surgical periodontal therapy 16, 17, 27, 37, 36 22, 26, 45, 35 44 Non-surgical periodontal therapy 37 15, 16, 25, 35 42, 13 13, 43, 44, 47 13, 14, 15
Interval between tooth extraction and denosumab initiation 3 weeks*** 3 weeks*** 3 months 3 months Not concerned 3 months 3 months 3 months 3 months 3 months
Total follow-up from denosumab initiation 29 months 15 months 18 months 34 months 15 months 30 months 34 months 23 months 22 months 22 months
Number of injections at the time of MRONJ diagnosis 10 12 8 24 12 19 20 12 15 11
MRONJ management at the end of follow up Conservative / Surgery$ Conservative Conservative Conservative Conservative Conservative / Surgery$ Conservative / Surgery$ Conservative Conservative Conservative / Surgery$
MRONJ status at the end of follow up Remission Unknown / death
(during the temporization period)
Stabilization (during the temporization period) Stabilization (during the temporization period) Unknown / death
(during the temporization period)
Improvement (during the healing period£) Improvement (during the healing period£) Stabilization (during the temporization period) Stabilization (during the temporization period) Worsening
(after surgery)
Follow-up after MRONJ diagnosis 16 months
(10 months after MRONJ management)
4 months 4 months 5 months 2 months 8 months
(1month after MRONJ management
7 months,
(1month after MRONJ management)
6 months 1 months 10 months
(1 month after surgery)
Denosumab reintroduction Yes, without recurrence after 4 injections / / / / Considered / / / /

Max: maxillary denture / Md: mandibular denture.

MRONJ: Medication-related osteonecrosis of the jaw.

* Dental check-up: presence of a dental pathology at the prophylactic visit.

** Periodontal disease: “-” absence of periodontal disease, “+” chronic and stable periodontitis, “+++” severe periodontal disease.and acute infection.

*** No radiographic control was performed to control the bone remodeling achievement.

$ Conservative / Surgery: conservative management was put in place during the period of decreasing effectiveness of the antiresorptive drug, then the MRONJ surgical management was performed.

€ Temporization period: period of decreasing effectiveness of the antiresorptive drug, from 5 to 9 months, depending on the exposure duration.

£ Healing period: period of bone healing after the MRONJ surgery.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.